Blog >
Welcoming New Member Sumin Koo

Blog

Welcoming New Member Sumin Koo

Umbrex is pleased to welcome Sumin Koo with BioMed Resolve.  Sumin began her career in McKinsey & Co’s healthcare practice. She served pharma and biotech clients, focused on Merger & Acquisitions and R&D strategy / operations. Post-McKinsey, she joined Novartis to run late-stage clinical trials and shepherded assets through to obtain FDA License approvals. She later became Vice President of Haemonetics, a $4B medical device public company, supporting the CEO as Chief of Staff on the company’s turnaround.

Most recently, she led the due diligence for impact investors on a £80M acquisition of a distressed diagnostic company during her time at Bill and Melinda Gates Foundation. She was subsequently appointed by the NewCo’s Board Chair to be its interim CEO to lead its turnaround.